Concepedia

Marcus Neureither

MN

Statistics

Publications

6

Citations

356

H-Index

6

Active since

1996

Affiliations

Biogen (Germany)(Current)

Goethe University Frankfurt

Dermatologikum Hamburg

GlaxoSmithKline (Germany)

University Hospital Frankfurt

Marcus Neureither is an author at Biogen (Germany) specializing in pharmacotherapy, clinical pharmacology, and medicine.

Publications per year

1996–2014

6

Publications

6

Efficacy and safety of fumaric acid esters in the long‐term treatment of psoriasis – A retrospective study (FUTURE)

Kristian Reich, Diamant Thaçi, Ulrich Mrowietz et al. · JDDG Journal der Deutschen Dermatologischen Gesellschaft · 2009 · 127 citations

, , +13

Safety and Efficacy of Vardenafil, a Selective Phosphodiesterase 5 Inhibitor, in Patients with Erectile Dysfunction and Arterial Hypertension Treated with Multiple Antihypertensives

H. van Ahlen, Klaus W.J. Wahle, W. Küpper et al. · The Journal of Sexual Medicine · 2005 · 78 citations

, , +17

Efficacy and Safety of Flexible-Dose Vardenafil in Men with Type 1 Diabetes and Erectile Dysfunction

Dan Ziegler, Frank Merfort, H. van Ahlen et al. · The Journal of Sexual Medicine · 2006 · 69 citations

, , +9

Fumaderm <sup>®</sup> in daily practice for psoriasis: dosing, efficacy and quality of life

Francis O. Walker, Annette Adamczyk, Christina Kellerer et al. · British Journal of Dermatology · 2014 · 41 citations

, , +10

Efficacy and safety of fumaric acid esters in patients with psoriasis on medication for comorbid conditions – a retrospective evaluation (FACTS)

Diamant Thaçi, Peter Weisenseel, Sandra Philipp et al. · JDDG Journal der Deutschen Dermatologischen Gesellschaft · 2013 · 26 citations

, , +13

1–5 of 6